Dr. David Chris Pound, MD

Dr. Pound practices at Hendricks Regional Health Danville Hospital in Danville, Indiana, part of Hendricks Regional Health.

Dr. Pound's NPI, 1760488563, was assigned on June 27, 2005. Dr. Pound holds Indiana license 01030255A.

Dr. Pound's primary practice is Hendricks Regional Health Danville Hospital, at 1000 E Main St, Danville, IN 46122 in Hendricks County. The practice phone is (317) 745-4451.

Dr. Pound's primary practice is Hendricks Regional Health Danville Hospital in Danville, Indiana, part of Hendricks Regional Health. The medical group on file is Hendricks Rheumatology. Dmand AI also links Dr. Pound to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pound practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Pound's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Pound is licensed in Indiana.

CMS data shows 216 Medicare services from Dr. Pound across 7 procedure codes in 2024, for 160 Medicare patients. Medicare paid $24,586 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 160 Medicare patients who saw Dr. Pound in 2024. The largest group is 65 to 74, with 93 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Pound's median patient age at 68, with 51% women.

In 2021, Dr. Pound wrote 48 Medicare Part D claims. They cover 2 drugs, with $73,963 in total drug cost. In 2020, CMS named 304 claims across 11 drugs.

CMS counts 39 procedures of colonoscopy by Dr. Pound, more than 58% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Pound, published from 2010 to 2020. The most frequent topics are Capsule Endoscopy and Colonic Polyps. Dr. Pound's most frequent co-authors are David M. Kastenberg, MD, Kris V. Kowdley, MD and Paul Yien Kwo, MD.

Dmand AI links Dr. Pound to 5 clinical trials, 2 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Liver Cirrhosis, Biliary, Cholestasis, Intrahepatic and Hepadnaviridae Infections. Intercept Pharmaceuticals sponsors the most, 2.

CMS Open Payments shows 442 general payments to Dr. Pound from 22 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 81% of the total. Gilead Sciences, Inc. paid the most, $251,167. It also lists 2 research payments totaling $1,529 in 2019.